Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $4.07 billion versus the consensus estimate of $3.83 billion.

Guidance:

Bristol-Myers Squibb sees FY2015 EPS of $1.85-$1.90, versus the consensus of $1.84.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.